RespiDerm's Unattributed Round

RespiDerm raised a round of funding on April 27, 2018.

Airjector, developed by RespiDerm, is a patented, noninvasive, handheld transdermal Pharmacopeia and medical gas applicator and therapeutic wound and cardiovascular treatment system.…

Articles about RespiDerm's Unattributed Round: